Vertex Pharmaceuticals (VRTX) Profit After Tax (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.41% |
| Dec 31, 2025 | 9.99% |
| Sep 30, 2025 | 4.84% |
| Jun 30, 2025 | 59.82% |
| Mar 31, 2025 | -29.21% |
| Dec 31, 2024 | -12.67% |
| Sep 30, 2024 | 129.09% |
| Jun 30, 2024 | -426.81% |
| Mar 31, 2024 | 13.50% |
| Dec 31, 2023 | -6.42% |
| Sep 30, 2023 | 13.06% |
| Jun 30, 2023 | 30.85% |
| Mar 31, 2023 | -14.54% |
| Dec 31, 2022 | -11.99% |
| Sep 30, 2022 | 14.81% |
| Jun 30, 2022 | 6.35% |
| Mar 31, 2022 | -1.04% |
| Dec 31, 2021 | -9.60% |
| Sep 30, 2021 | 1,171.49% |
| Jun 30, 2021 | -89.74% |
| Mar 31, 2021 | 8.10% |
| Dec 31, 2020 | -9.48% |
| Sep 30, 2020 | -20.28% |
| Jun 30, 2020 | 38.91% |
| Mar 31, 2020 | 3.35% |
| Dec 31, 2019 | 914.00% |
| Sep 30, 2019 | -78.49% |
| Jun 30, 2019 | -0.45% |
| Mar 31, 2019 | -82.67% |
| Dec 31, 2018 | 1,104.33% |
| Sep 30, 2018 | -37.91% |
| Jun 30, 2018 | -1.38% |
| Mar 31, 2018 | 108.83% |
| Dec 31, 2017 | 134.57% |
| Sep 30, 2017 | -1,718.51% |
| Jun 30, 2017 | -92.79% |
| Mar 31, 2017 | 798.98% |
| Dec 31, 2016 | 171.47% |
| Sep 30, 2016 | -7.44% |
| Jun 30, 2016 | 13.16% |